CGIX

CGIX Stock: Why Cancer Genetics Shares Are Rocketing Higher Today

By Robert Lakin, InvestorPlace Contributor
Cancer Genetics said its board has approved the StemoniX merger, setting the stage for a March shareholder vote. In the wake of the move, investors drove up the CGIX stock price in Wednesday's premarket trading.

3 ‘Ground Floor’ Startup Investments on Netcapital

By Josh Enomoto, InvestorPlace Contributor
Thanks to the innovative platform of Netcapital, everyday folks have a chance to participate in private equity. Here are three startup investments to consider.

Cancer Genetics News: Why CGIX Stock Is Rocketing Today

By Nick Clarkson, Web Editor
Cancer Genetics' news of a merger with major drug developer StemoniX has CGIX stock skyrocketing higher on Monday morning.